JPRN-UMIN000007733已完成3 期
Helicobacter pylori eradication one-week triple therapy with esomeprazole versus lansoprazole, amoxicillin and clarithromycin: a randomized, open-label, non-inferiority trial. - Helicobacter pylori eradication one-week triple therapy with esomeprazole, amoxicillin and clarithromycin
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 260
研究概览
简要总结
Esomeprazole showed non-inferiority and safety in a 7 day-triple therapy for eradication of H. pylori compared with lansoprazole.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Past history of allergy for the drugs used in this study. Past history of taking eradication therapy. Past history of gastrectomy. Gastric cancer patients, pregnancy or lactation. Severe renal dysfunction, Blood disease, Infectious Mononucleosis Patients who are disqualified for the study by their physicians
研究者
相似试验
已完成
4 期
Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple TherapyGastric CancerGastritisDyspepsiaHelicobacter Pylori InfectionPeptic UlcerNCT04678492Xijing Hospital of Digestive Diseases658
Unknown
4 期
Increased Re-eradication Rate of Helicobacter Pylori by Adding N-acetylcystein or Metronidazole to the Triple TherapyBacterial Infection Due to Helicobacter Pylori (H. Pylori)NCT01572597Buddhist Tzu Chi General Hospital120
招募中
4 期
Vonoprazan Hp Dual or Triple Eradication RegimesHelicobacter PyloriNCT05345210Xijing Hospital of Digestive Diseases500
已完成
4 期
Evaluation of third-line eradication for H. pylori infection in JapaThe patients after unseccessful 1st and 2nd line eradicationtreatmentJPRN-UMIN000007632Japan Gast Study Group150
已完成
4 期
Vonoprazan-Based Triple Therapy in Comparison With Extended Sequential TherapyHelicobacter PyloriNCT05371249Fu Jen Catholic University Hospital628